If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Thought Leader Services
Download FREE Excerpt
10 Info Graphics
14 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
With so many of its activities affecting new product development and performance, medical affairs is recognized as one of the most important functions within pharma organizations. Thought leader management is one of the critical responsibilities of medical affairs groups because companies look to thought leaders to inform and guide clinical programs.
Some of the key components of an effective thought leader management program include its leadership structure and approach to relationship development. Best Practices LLC performed this research study to identify how leading pharma companies structure and organize their thought leader management organizations, to examine the drivers of thought leader management relationships and to highlight new technologies used to maintain relationships.
The benchmark data in this study will help companies find better ways to create effective thought leader management strategies that will enhance and inform a critical aspect of an organization’s operations. This document includes mature and emerging markets segment analysis.
Health Care; Pharmaceutical; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Chemical; Manufacturing; Medical Device; Consumer Products; Diagnostic; Technology
Sanofi; Shire; Astellas; AstraZeneca; Genentech; Dr Reddy's Laboratories; Biogen; Merck; Eli Lilly; Teva Pharmaceutical Industries Ltd; Biocon; United Therapeutics; Amgen; Baxter Healthcare; Acorda Therapeutics; Upsher-Smith; Crescendo Bioscience; ProStrakan; Cubist Pharmaceuticals; Pierre Fabre Medicament; Ironwood; Kadmon Pharmaceuticals; Covidien; Roche; Medtronic; GE Healthcare; Bayer Healthcare; BARD; BD